Career history of Anthony W. Fox
Former positions of Anthony W. Fox
| Companies | Position | Start | End |
|---|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
EBD Group, Inc.
 EBD Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Informa Plc, EBD Group, Inc. operates as a partnering company for the life science industry. The company is based in Carlsbad, CA. EBD Group was acquired by Informa Switzerland Ltd. on June 07, 2013. | President | 09/09/2009 | - |
| Cypros Pharmaceutical Corp. | Corporate Officer/Principal | - | - |
| HISTOGEN INC. | Chief Tech/Sci/R&D Officer | - | - |
Symphony Allegro, Inc.
 Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Director/Board Member | - | - |
Training of Anthony W. Fox
| University of London | Undergraduate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Symphony Allegro, Inc.
Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Health Technology |
| Cypros Pharmaceutical Corp. | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
EBD Group, Inc.
EBD Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Informa Plc, EBD Group, Inc. operates as a partnering company for the life science industry. The company is based in Carlsbad, CA. EBD Group was acquired by Informa Switzerland Ltd. on June 07, 2013. | Commercial Services |
| Glaxo, Inc. |
- Stock Market
- Insiders
- Anthony W. Fox
- Experience
